Profil
Michael Schönhofen is currently the President-Biopharma at Fresenius Kabi AG.
Previously, he worked as a Non-Executive Director at Fresenius Kabi Oncology Ltd. from 2008 to 2023.
He holds a doctorate degree from Technische Universität Darmstadt.
Postes actifs de Michael Schönhofen
| Sociétés | Poste | Début |
|---|---|---|
Fresenius Kabi AG
Fresenius Kabi AG BiotechnologyHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Corporate Officer/Principal | - |
Anciens postes connus de Michael Schönhofen
| Sociétés | Poste | Fin |
|---|---|---|
| FRESENIUS KABI ONCOLOGY LTD | Directeur Technique/Scientifique/R&D | 13/01/2010 |
Formation de Michael Schönhofen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Fresenius Kabi AG
Fresenius Kabi AG BiotechnologyHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Health Technology |
Technische Universität Darmstadt
Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fresenius Kabi Oncology Ltd.
Fresenius Kabi Oncology Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures and markets cancer research and anticancer products | Commercial Services |
















